Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAF1 | P04049 | 15/20 | 0.53 |
| ▸ | BRAF | P15056 | 15/20 | 0.53 |
| ▸ | CSF1R | P07333 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | STAT3 | P40763 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | BTK | Q06187 | 1/20 | 0.47 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.47 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5490015 | 0.98 | RAF1 (0.52) | RAF1BRAFCSF1RMAPTSTAT3 | |
| SCHEMBL14534471 | 0.90 | MAPK14 (0.50) | RAF1BRAF | |
| SCHEMBL4417256 | 0.89 | RAF1 (0.52) | RAF1BRAFCSF1RMAPTSTAT3 | |
| SCHEMBL4551612 | 0.89 | RAF1 (0.52) | RAF1BRAFCSF1R | |
| SCHEMBL4409370 | 0.88 | RAF1 (0.51) | RAF1BRAFCSF1R | |
| SCHEMBL4551616 | 0.87 | MAPK14 (0.49) | RAF1BRAF | |
| SCHEMBL5484352 | 0.86 | CSF1R (0.50) | RAF1BRAFCSF1RTNK2MAP4K2 | |
| SCHEMBL5485734 | 0.85 | RAF1 (0.51) | RAF1BRAFCSF1R | |
| SCHEMBL14534694 | 0.83 | MAPK14 (0.45) | RAF1BRAFMAPTSMN1; SMN2 | |
| SCHEMBL5487782 | 0.83 | RAF1 (0.57) | RAF1BRAFCSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2035005-A2 | THERAPY USING CYTOKINE INHIBITORS | Kemia, INC. (US) | 2009-03-18 | — | — | EP | disclosed |
| WO-2007146712-A2 | THERAPY USING CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007056016-A2 | BISAMIDE CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007056016-A2 | BISAMIDE CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-05-18 | — | — | WO | disclosed |